|
1
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goerner M, Seiwert TY and Sudhoff H:
Molecular targeted therapies in head and neck cancer-an update of
recent developments. Head Neck Oncol. 2:82010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hartwell JL: Plants Used Against Cancer: A
Survey. Bioactive Plants Vol II. Quarterman Publications; Lawrence,
MA: 1982
|
|
4
|
Danilos J, Zbroja-Sontag W, Baran E,
Kurylcio L, Kondratowicz L and Jusiak L: Preliminary studies on the
effect of Ukrain
(Tris(2-([5bS-(5ba,6b,12ba)]-5b,6,7,12b,13,14-hexahydro-13-methyl[1,3]
benzodioxolo[5,6-v]-1-3-dioxolo[4,5-i]phenanthridinium-6-ol]-ethaneaminyl)phosphinesulfide.6HCl)
on the immunological response in patients with malignant tumours.
Drugs Exp Clin Res. 18 (Suppl):S55–S62. 1992.
|
|
5
|
Hohenwarter O, Strutzenberger K, Katinger
H, Liepins A and Nowicky JW: Selective inhibition of in vitro cell
growth by the anti-tumour drug Ukrain. Drugs Exp Clin Res. 18
(Suppl):S1–S4. 1992.
|
|
6
|
Sotomayor EM, Rao K, Lopez DM and Liepins
A: Enhancement of macrophage tumouricidal activity by the alkaloid
derivative Ukrain. In vitro and in vivo studies. Drugs Exp Clin
Res. 18 (Suppl):S5–S11. 1992.
|
|
7
|
Kadan P, Korsh OB and Hiesmayr W: Ukrain
in the treatment of urethral recurrent carcinoma (case report).
Drugs Exp Clin Res. 22:271–273. 1996.PubMed/NCBI
|
|
8
|
Lohninger A, Korsh OB and Melnyk A:
Combined therapy with Ukrain and chemotherapy in ovarian cancer
(case report). Drugs Exp Clin Res. 22:259–262. 1996.PubMed/NCBI
|
|
9
|
Schramm E, Nowicky JW and Godysh Y:
Biophysiological effects of Ukrain therapy in a patient with breast
cancer (case report). Drugs Exp Clin Res. 22:247–254.
1996.PubMed/NCBI
|
|
10
|
Habermehl D, Kammerer B, Handrick R, Eldh
T, Gruber C, Cordes N, Daniel PT, Plasswilm L, Bamberg M, Belka C
and Jendrossek V: Proapoptotic activity of Ukrain is based on
Chelidonium majus L. alkaloids and mediated via a
mitochondrial death pathway. BMC Cancer. 6:142006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lanvers-Kaminsky C, Nolting DM, Köster J,
Schröder A, Sandkötter J and Boos J: In-vitro toxicity of Ukrain
against human Ewing tumor cell lines. Anticancer Drugs.
17:1025–1030. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Panzer A, Hamel E, Joubert AM, Bianchi PC
and Seegers JC: Ukrain(TM), a semisynthetic Chelidonium
majus alkaloid derivative, acts by inhibition of tubulin
polymerization in normal and malignant cell lines. Cancer Lett.
160:149–157. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Panzer A, Joubert AM, Bianchi PC and
Seegers JC: The antimitotic effects of Ukrain, a Chelidonium
majus alkaloid derivative, are reversible in vitro. Cancer
Lett. 150:85–92. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gagliano N, Moscheni C, Torri C, Donetti
E, Magnani I, Costa F, Nowicky W and Gioia M: Ukrain modulates
glial fibrillary acidic protein, but not connexin 43 expression,
and induces apoptosis in human cultured glioblastoma cells.
Anticancer Drugs. 18:669–676. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Herrmann R, Roller J, Polednik C and
Schmidt M: Effect of chelidonine on growth, invasion, angiogenesis
and gene expression in head and neck cancer cell lines. Oncol Lett.
16:3108–3116. 2018.PubMed/NCBI
|
|
16
|
Zenner HP, Lehner W and Herrmann IF:
Establishment of carcinoma cell lines from larynx and submandibular
gland. Arch Otorhinolaryngol. 225:269–277. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schmidt M, Grünsfelder P and Hoppe F:
Induction of matrix metalloproteinases in keratinocytes by
cholesteatoma debris and granulation tissue extracts. Eur Arch
Otorhinolaryngol. 257:425–429. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vermes I, Haanen C, Steffens-Nakken H and
Reutelingsperger C: A novel assay for apoptosis. Flow cytometric
detection of phosphatidylserine expression on early apoptotic cells
using fluorescein labelled Annexin V. J Immunol Methods. 184:39–51.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bolstad BM, Irizarry RA, Astrand M and
Speed TP: A comparison of normalization methods for high density
oligonucleotide array data based on variance and bias.
Bioinformatics. 19:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
El-Readi MZ, Eid S, Ashour ML, Tahrani A
and Wink M: Modulation of multidrug resistance in cancer cells by
chelidonine and Chelidonium majus alkaloids. Phytomedicine.
20:282–294. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jesionek W, Fornal E, Majer-Dziedzic B,
Móricz AM, Nowicky W and Choma IM: Investigation of the composition
and antibacterial activity of Ukrain™ drug using liquid
chromatography techniques. J Chromatogr A. 1429:340–347. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kulp M and Bragina O: Capillary
electrophoretic study of the synergistic biological effects of
alkaloids from Chelidonium majus L. in normal and cancer
cells. Anal Bioanal Chem. 405:3391–3397. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Malíková J, Zdarilová A, Hlobilková A and
Ulrichová J: The effect of chelerythrine on cell growth, apoptosis,
and cell cycle in human normal and cancer cells in comparison with
sanguinarine. Cell Biol Toxicol. 22:439–453. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mochly-Rosen D, Das K and Grimes KV:
Protein kinase C, an elusive therapeutic target? Nat Rev Drug
Discov. 11:937–957. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jana J, Mondal S, Bhattacharjee P,
Sengupta P, Roychowdhury T, Saha P, Kundu P and Chatterjee S:
Chelerythrine downregulates expression of VEGFA, BCL2 and KRAS by
arresting G-Quadruplex structures at their promoter regions. Sci
Rep. 7:407062017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Banerjee A, Sanyal S, Dutta S, Chakraborty
P, Das PP, Jana K, Vasudevan M, Das C and Dasgupta D: The plant
alkaloid chelerythrine binds to chromatin, alters H3K9Ac and
modulates global gene expression. J Biomol Struct Dyn.
35:1491–1499. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chmura SJ, Dolan ME, Cha A, Mauceri HJ,
Kufe DW and Weichselbaum RR: In vitro and in vivo activity of
protein kinase C inhibitor chelerythrine chloride induces tumor
cell toxicity and growth delay in vivo. Clin Cancer Res. 6:737–742.
2000.PubMed/NCBI
|
|
30
|
Zhu Y, Pan Y, Zhang G, Wu Y, Zhong W, Chu
C, Qian Y and Zhu G: Chelerythrine inhibits human hepatocellular
carcinoma metastasis in vitro. Biol Pharm Bull. 41:36–46. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Koshelnick J, Moskvina E, Binder BR and
Nowicky JW: Ukrain (NSC-631570) inhibits angiogenic differentiation
of human endothelial cells in vitro. 17th International Cancer
Congress Brazil: pp. 91–95. 1998
|
|
32
|
Rodriguez M and Potter DA: CYP1A1
regulates breast cancer proliferation and survival. Mol Cancer Res.
11:780–792. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Androutsopoulos VP, Tsatsakis AM and
Spandidos DA: Cytochrome P450 CYP1A1: Wider roles in cancer
progression and prevention. BMC Cancer. 9:1872009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Orland A, Knapp K, König GM,
Ulrich-Merzenich G and Knöß W: Combining metabolomic analysis and
microarray gene expression analysis in the characterization of the
medicinal plant Chelidonium majus L. Phytomedicine.
21:1587–1596. 2014. View Article : Google Scholar : PubMed/NCBI
|
